0
0
0
Increasing Medication Access for Seniors Act of 2024
12/19/2024, 9:06 AM
Summary of Bill HR 8725
Bill 118 hr 8725, also known as the Increasing Medication Access for Seniors Act of 2024, aims to improve access to affordable prescription medications for senior citizens in the United States. The bill was introduced in the House of Representatives in response to concerns about rising drug prices and the financial burden this places on older Americans.
The key provisions of the bill include:
1. Allowing Medicare to negotiate drug prices with pharmaceutical companies: Currently, Medicare is prohibited from negotiating directly with drug manufacturers for lower prices. This bill would change that, allowing Medicare to use its purchasing power to negotiate better deals for prescription medications. 2. Expanding access to generic drugs: The bill includes measures to encourage the development and availability of generic versions of brand-name drugs. This would help lower costs for seniors by providing more affordable alternatives to expensive brand-name medications. 3. Increasing transparency in drug pricing: The bill requires pharmaceutical companies to disclose information about the costs of producing and marketing their drugs. This transparency would help identify instances of price gouging and hold drug manufacturers accountable for their pricing practices. 4. Providing financial assistance for low-income seniors: The bill includes provisions to help low-income seniors afford their medications, such as expanding eligibility for Medicare's Extra Help program and increasing funding for prescription drug assistance programs. Overall, the Increasing Medication Access for Seniors Act of 2024 aims to address the challenges that many seniors face in accessing affordable prescription medications. By allowing Medicare to negotiate drug prices, expanding access to generic drugs, increasing transparency in drug pricing, and providing financial assistance for low-income seniors, the bill seeks to make prescription medications more affordable and accessible for older Americans.
The key provisions of the bill include:
1. Allowing Medicare to negotiate drug prices with pharmaceutical companies: Currently, Medicare is prohibited from negotiating directly with drug manufacturers for lower prices. This bill would change that, allowing Medicare to use its purchasing power to negotiate better deals for prescription medications. 2. Expanding access to generic drugs: The bill includes measures to encourage the development and availability of generic versions of brand-name drugs. This would help lower costs for seniors by providing more affordable alternatives to expensive brand-name medications. 3. Increasing transparency in drug pricing: The bill requires pharmaceutical companies to disclose information about the costs of producing and marketing their drugs. This transparency would help identify instances of price gouging and hold drug manufacturers accountable for their pricing practices. 4. Providing financial assistance for low-income seniors: The bill includes provisions to help low-income seniors afford their medications, such as expanding eligibility for Medicare's Extra Help program and increasing funding for prescription drug assistance programs. Overall, the Increasing Medication Access for Seniors Act of 2024 aims to address the challenges that many seniors face in accessing affordable prescription medications. By allowing Medicare to negotiate drug prices, expanding access to generic drugs, increasing transparency in drug pricing, and providing financial assistance for low-income seniors, the bill seeks to make prescription medications more affordable and accessible for older Americans.
Current Status of Bill HR 8725
Bill HR 8725 is currently in the status of Bill Introduced since June 13, 2024. Bill HR 8725 was introduced during Congress 118 and was introduced to the House on June 13, 2024. Bill HR 8725's most recent activity was Referred to the Subcommittee on Health. as of December 17, 2024
Bipartisan Support of Bill HR 8725
Total Number of Sponsors
2Democrat Sponsors
2Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
2Democrat Cosponsors
0Republican Cosponsors
2Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 8725
Primary Policy Focus
HealthAlternate Title(s) of Bill HR 8725
To require the Secretary of Health and Human Services to submit to Congress a report on the option to elect to pay cost-sharing under a prescription drug plan or MA-PD plan in monthly capped amounts.
To require the Secretary of Health and Human Services to submit to Congress a report on the option to elect to pay cost-sharing under a prescription drug plan or MA-PD plan in monthly capped amounts.
Comments
Sponsors and Cosponsors of HR 8725
Latest Bills
TRAPS Act
Bill HR 4936September 18, 2026
Apples to Apples Comparison Act of 2025
Bill HR 4093September 18, 2026
American Lending Fairness Act of 2026
Bill HR 7866September 18, 2026
Civil Investigative Demand Reform Act of 2025
Bill HR 1653September 18, 2026
American Reserve Modernization Act of 2026
Bill HR 8957September 18, 2026
Preventive Health Savings Act
Bill HR 4464September 18, 2026
PEARL Act
Bill HR 9327September 18, 2026
Medically Tailored Home-Delivered Meals Program Pilot Act
Bill HR 5439September 18, 2026
To designate the facility of the United States Postal Service located at 117 West Lovett Street in Charlotte, Michigan, as the "Francis C. Flaherty Post Office Building".
Bill HR 9570September 18, 2026
To designate the facility of the United States Postal Service located at 1019 Avenue H in Fort Madison, Iowa, as the "Martin L. Graber Post Office".
Bill HR 4707September 18, 2026


